Additional file 1 of A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker

Authors :: Kelley, Kristen C.
Grossman, Kenneth F.
Brittain-Blankenship, Mary
Thorne, Kelli M.
Akerley, Wallace L.
Terrazas, Moises C.
Kosak, Ken M.
Boucher, Kenneth M.
Buys, Saundra S.
McGregor, Kimberly A.
Werner, Theresa L.
Agarwal, Neeraj
Weis, John R.
Sharma, Sunil
Ward, John H.
Kennedy, Thomas P.
Sborov, Douglas W.
Shami, Paul J.
Publication Year :: 2021
Publisher :: figshare, 2021.
Abstract: Additional file 1: Supplementary Table 1. Clinical trials investigating disulfiram in patients with solid tumors. Supplementary Table 2. Characteristics of non-evaluable patients.

Full Text Access

Tools